✦ LIBER ✦

Special considerations in safety pharmacology: Biologicals

✍ Scribed by Hugo M. Vargas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biologic Agents in Rheumatology: Safety

✍ LEE, SUSAN J.; KAVANAUGH, ARTHUR 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

General pharmacology/safety pharmacology

✍ Lewis B. Kinter 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Safety considerations in the pharmacolog

✍ A. John Camm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Nonclinical strategy considerations for

✍ Vargas, Hugo M; Amouzadeh, Hamid R; Engwall, Michael J 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 329 KB

Statistical considerations on the power

✍ Dingzhou Dean Li 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Nonclinical Development of Novel Biologi

✍ Wolf, Jayanthi J. 📂 Article 📅 2013 🏛 Elsevier ⚖ 254 KB